Evaluation of a novel automated chemiluminescent assay system for antimicrobial susceptibility testing

Journal of Clinical Microbiology

Volumn 41, Issue 1, 2003, Pages 279-284

  Manome, Isao ^a   Ikedo, Masanari ^a   Saito, Yoshihiko ^b   Ishii, Keiko Kumura ^b   Kaku, Mitsuo ^b  

^a EIKEN CHEMICAL CO LTD   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFDITOREN; CEFOTAXIME; CEFOTIAM; CEFPODOXIME; CEFTAZIDIME; CLARITHROMYCIN; CLINDAMYCIN; FLOMOXEF; FOSFOMYCIN; HABEKACIN; IMIPENEM; LEVOFLOXACIN; MINOCYCLINE; OXACILLIN; OXYGEN; PENICILLIN G; PIPERACILLIN; TEICOPLANIN; VANCOMYCIN;

ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; AUTOMATION; BACTERIUM ISOLATE; CHEMOLUMINESCENCE; CITROBACTER FREUNDII; COAGULASE NEGATIVE STAPHYLOCOCCUS; DILUTION; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EVALUATION; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; RELIABILITY; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; AUTOMATION; BACTERIA; CHEMILUMINESCENT MEASUREMENTS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; REAGENT KITS, DIAGNOSTIC; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; MIRABILIS; MORGANELLA MORGANII; NEGIBACTERIA; POSIBACTERIA; PROTEUS MIRABILIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0037232054     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.1.279-284.2003     Document Type: Article

References (18)

1. Baker, C. N., and F. C. Tenover. 1996. Evaluation of Alamar colorimetric microdilution susceptibility testing method for staphylococci and enterococci. J. Clin. Microbiol. 34:2654-2659.
2. Campbell, A. K., M. B. Hallett, and I. Weeks. 1985. Chemiluminescence as an analytical tool in cell biology and medicine. Method Biochem. Anal. 31:317-416.
3. a.Chapman, A. G., and D. E. Atkinson. 1977. Adenine nucleotide concentrations and turnover rates. Their correlation with biological activity in bacteria and yeast. Adv. Microb. Physiol. 15:253-306.
4. Clairoux, N., M. Picard, A. Brochu, N. Rousseau, P. Gourde, D. Beauchamp, T. R. Parr, Jr., M. G. Bergeron, and F. Malouin. 1992. Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibodies in strains of Haemophilus influenzae isolated in Canada. Antimicrob. Agents Chemother. 36:1504-1513.
5. Di Bonaventura, G., E. Ricci, N. D. Loggia, G. Catamo, and R. Piccolomini. Evaluation of the E test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization. J. Clin. Microbiol. 36:824-826.
6. Endtz, H. P., N. V. D. Braak, A. V. Belkum, W. H. Goessens, D. Kreft, A. B. Stroebel, and H. A. Verbrugh. 1998. Comparison of eight methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 36:592-594.
7. Goto, S., S. Miyazaki, and Y. Ishida. 1992. In vitro and in vivo antibacterial activities of a new quinolone, levofloxacin (DR-3355). Chemotherapy 40:14-26.
8. Jorgensen, J. H., A. W. Howell, and A. A. Maher. 1991. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. J. Clin. Microbiol. 29:109-114.
9. Jorgensen, J. H., M. L. McElmeel, and S. A. Crawford. 1998. Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcuspneumoniae challenge strains and recent clinical isolates. J. Clin. Microbiol. 36:788-791.
10. Jorgensen, J. H., A. L. Barry, M. M. Traczewski, D. F. Sahm, M. L. McElmeel, and S. A. Crawford. 2000. Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2. J. Clin. Microbiol. 38:2814-2818.
11. Manafi, M., W. Kneifel, and S. Bascomb. 1991. Fluorogenic and chromogenic substrates used in bacteria diagnostics. Microbiol. Rev. 55:335-348.
12. Molin, O., L. Milson, and S. Ansehn. 1983. Rapid detection of bacterial growth in blood cultures: bioluminescent assay of bacterial ATP. J. Clin. Microbiol. 18:521-525.
13. National Committee for Clinical Laboratory Standards. 1997. Approved standard M7-A4, M100-S8. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS, Wayne, Pa.
14. National Committee for Clinical Laboratory Standards. 1997. Approved standard M2-A6, M100-S8. Performance standards for antimicrobial disk susceptibility tests. NCCLS, Wayne, Pa.
15. National Committee for Clinical Laboratory Standards. 2000. Approved standard M7-A5, M100-S10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS, Wayne, Pa.
16. Nishino, T., M. Tanaka, Y. Aono, T. Iwai, and M. Otsuki. 1992. In vitro and in vivo antibacterial activity of levofloxacin. Chemotherapy 40:36-50.
17. Yamashoji, S., T. Ikeda, and K. Yamashoji. 1989. Chemiluminescent assay for determination of viable cell density of yeast, mammalian, and plant cells. Anal. Biochem. 181:149-152.
18. 2-production by Escherichia coli: application of the rapid chemiluminescent assay to antimicrobial susceptibility testing. Microbiol. Immunol. 45:333-340.